Daniel Blair, PhD

St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.

Sometimes a scientist’s next step isn’t a step, but more of a career-defining leap. Early-career investigator Lily Guenther, MD, shares her experience of taking that leap and starting a laboratory at St. Jude.

St. Jude computational biologists created a computational score predicting cancer drug sensitivity to HDAC6 inhibitors in a promising phase Ib clinical trial.

St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.

St. Jude scientists have learned that bacteria are more successful at developing antibiotic resistance when they swap genes through recombination.

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

The 2022 St. Jude Global Alliance Convening brought together researchers from around the globe working to advance cures for children with catastrophic childhood diseases.

Stacey Ogden, PhD, shares mentoring advice for scientists setting up their first laboratory as a principal investigator.

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.